SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fredun Pharmaceuticals gets nod to manufacture Xenografts

15 Mar 2022 Evaluate

Fredun Pharmaceuticals has received the approval for manufacturing Xenografts for various Dental and Orthopaedic surgical appliances from Central Drugs Standard Control Organisation (COSCO), India. With this, the Company aims to penetrate the Dental fraternity across India. With many doctors now using grafts, company expanding product portfolio with this new addition to take advantage of the growing opportunity.

Fredun Pharmaceuticals was established to produce drugs of international standards at affordable prices. The company produces anti -bacterial, anti-malarial, anti-diabetic tablets, capsules and dry syrups.

Fredun Pharma Share Price

2297.80 -11.05 (-0.48%)
08-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1788.60
Dr. Reddys Lab 1275.75
Cipla 1388.25
Zydus Lifesciences 1087.45
Lupin 2252.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×